Evidence map›Paper›PMID 38427668›Full record

ArticlePloS one2024

Long-term in vitro monitoring of AAV-transduction efficiencies in real-time with Hoechst 33342.

Xiaonan Hu, Roland Meister, Jan Tode, Carsten Framme, Heiko Fuchs

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xiaonan HuInstitute of Ophthalmology, University Eye Hospital, Hannover Medical School, Hannover, Germany.
Roland MeisterInstitute of Ophthalmology, University Eye Hospital, Hannover Medical School, Hannover, Germany.
Jan TodeInstitute of Ophthalmology, University Eye Hospital, Hannover Medical School, Hannover, Germany.ORCID 0000-0003-2422-532X
Carsten FrammeInstitute of Ophthalmology, University Eye Hospital, Hannover Medical School, Hannover, Germany.
Heiko FuchsInstitute of Ophthalmology, University Eye Hospital, Hannover Medical School, Hannover, Germany.ORCID 0000-0001-9142-4084
Medizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adeno-associated viral transduction allows the introduction of nucleic fragments into cells and is widely used to modulate gene expressions in vitro and in vivo. It enables the study of genetic functions and disease mechanisms and, more recently, serves as a tool for gene repair. To achieve optimal transduction performance for a given cell type, selecting an appropriate serotype and the number of virus particles per cell, also known as the multiplicity of infection, is critical. Fluorescent proteins are one of the common reporter genes to visualize successfully transduced cells and assess transduction efficiencies. Traditional methods of measuring fluorescence-positive cells are endpoint analysis by flow cytometry or manual counting with a fluorescence microscope. However, the flow cytometry analysis does not allow further measurement in a test run, and manual counting by microscopy is time-consuming. Here, we present a method that repeatedly evaluates transduction efficiencies by adding the DNA-stain Hoechst 33342 during the transduction process combined with a microscope or live-cell imager and microplate image analysis software. The method achieves fast, high-throughput, reproducible, and real-time post-transduction analysis and allows for optimizing transduction parameters and screening for a proper approach.

Indexed as

BenzimidazolesCell NucleusColoring AgentsDependovirusMicroscopy, FluorescenceBenzimidazolesbisbenzimide ethoxide trihydrochlorideColoring Agents

Identifiers

PMID38427668
PMCPMC10906819
OpenAlexW4392388363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.